HAZEN MARSHALL

MARSHALL & POPP, LLC · Washington, DC · registered since 2024

Registered · LDAActive

Send proposal →Contact →Claim this profile →

At a glance

Registered since

2024

Senate LDA system

Clients

last 3 years

Filings

2 agencies contacted

Activity

filings by quarter

Works on

Background

Government experience

Policy Director-Senate Majority Leader Mitch McConnell; Staff Director/Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist

Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don Nickles

Disclosed on LD-2 filings

Policy Director-Senate Majority Leader Mitch McConnell; Staff Director

Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don Nickles

Disclosed on LD-2 filings

Policy Director

Senate Majority Leader Mitch McConnell; Staff Director, Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Ofﬁce of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don Nickles

Disclosed on LD-2 filings

Policy Director-Senate Majority Leader Mitch McConnell; Staff Director

Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Ofﬁce of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don Nickles

Disclosed on LD-2 filings

Policy Director

Senate Majority Leader Mitch McConnell; Staff Director, Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don Nickles

Disclosed on LD-2 filings

Policy Director-Senate Majority Leader Mitch McConnell; Staff Director

Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Asst. Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don Nickles

Disclosed on LD-2 filings

Career

MARSHALL & POPP, LLC

Washington, DC

2024 - present

Specific issues

Issues affecting the telecommunications industry, including broadband infrastructure and federal spectrum policy. Issues related to the Affordable Connectivity Fund.

Telecommunications · 2024 Q3

Issues related to the expensing of capital investment and research and development expenditures, including H.R. 7024, the Tax Relief for American Families and Workers Act.

Taxation/Internal Revenue Code · 2024 Q3

Issues related to intellectual property and patent reform, including: S. 150, Affordable Prescriptions for Patients Act; S. 79, Interagency Patent Coordination and Improvement Act; S. 113, Prescription Pricing for the People Act; S. 142, Preserve Access to Affordable Generics and Biosimilars Act; and S. 148, Stop STALLING Act.

Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169). Issues related to vaccine development, distribution and injury compensation. Issues related to insulin pricing. Issues related to FDA regulation of pharmaceuticals. Issues related to prescription drug pricing and pharmacy benefit manager business practices, including S. 127, Pharmacy Benefit Manager Transparency Act, S.1339 - Pharmacy Benefit Manager Reform Act, H.R. 2679, the PBM Accountability Act, H.R.4822 - Health Care Price Transparency Act, H.R. 5378 - Lower Costs, More Transparency Act. Issues related to the 340B program, including H.R. 3290, to ensure transparency and oversight of the 340B drug discount program. Pandemic All-Hazards Preparedness Act (PAHPA) reauthorization, including S.2333 - Pandemic and All-Hazards Preparedness and Response Act. Issues related to Type 1 diabetes screening.

Pharmacy · 2024 Q3

Issues related to vaccine excise taxes and the Vaccine Injury Compensation Fund.

Taxation/Internal Revenue Code · 2024 Q3

Issues related to waiving intellectual property protections for COVID-19 vaccines and thereaputics under the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement). Issues related to the National Institute of Standards and Technology request for public comment on a Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights.

Trade (domestic/foreign) · 2024 Q3